[1]李海峰,李振华,刘丽娟.急性缺血性脑卒中患者血清Survivin,Hepc25水平变化及其临床意义[J].卒中与神经疾病杂志,2022,29(05):432-437.[doi:10.3969/j.issn.1007-0478.2022.05.007]
　Li Haifeng*,Li Zhenhua,Liu Lijuan*..Changes in serum Survivin and Hepc25 levels in patients with acute ischemic stroke and their clinical significance[J].Stroke and Nervous Diseases,2022,29(05):432-437.[doi:10.3969/j.issn.1007-0478.2022.05.007]
点击复制

急性缺血性脑卒中患者血清Survivin,Hepc25水平变化及其临床意义()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第29卷
期数:
2022年05期
页码:
432-437
栏目:
论著
出版日期:
2022-10-10

文章信息/Info

Title:
Changes in serum Survivin and Hepc25 levels in patients with acute ischemic stroke and their clinical significance
文章编号:
1007-0478(2022)05-0432-06
作者:
李海峰; 李振华; 刘丽娟
455000 河南省安阳市人民医院急诊科(李海峰 刘丽娟),神经内科(李振华)
Author(s):
Li Haifeng*;  Li Zhenhua;  Liu Lijuan*.
*Department of Emergency, the People's Hospital of Anyang City, Anyang Henan 455000
关键词:
急性缺血性脑卒中; 生存素; 铁调素25; 预后
Keywords:
Acute ischemic stroke; Survivin; Hepcidin 25; Prognosis
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2022.05.007
文献标志码:
A
摘要:
目的 探讨急性缺血性脑卒中(Acute ischemic stroke,AIS)患者血清生存素(Survivin)、铁调素25(hepcidin 25,Hepc25)水平变化及其临床意义。方法 选取2019年6月-2021年6月安阳市人民医院收治的105例AIS患者为AIS组,另选取同期53例体检健康者为对照组; AIS组入院时根据美国国立卫生研究院卒中量表(National institutes of health stroke scale,NIHSS)评分将AIS组分为轻度缺损组31例、中度缺损组49例、重度缺损组25例,6个月后根据改良Rankin量表评分分为预后不良组42例和预后良好组63例; 采用酶联免疫吸附实验(Enzyme linked immunosorbent assay,ELISA)检测血清Survivin,Hepc25水平; Spearman相关系数分析AIS患者血清Survivin,Hepc25水平与NIHSS评分的相关性; 多因素Logistic回归分析AIS患者预后不良的影响因素; 受试者工作特征(Receiver operating characteristic,ROC)曲线分析血清Survivin,Hepc25水平预测AIS患者预后不良的价值。结果 AIS组血清Survivin,Hepc25水平高于对照组(P<0.05); 轻度、中度、重度缺损组血清Survivin,Hepc25水平依次升高(P<0.05)。Spearman相关系数显示,AIS患者血清Survivin,Hepc25水平与NIHSS评分呈正相关(r=0.693、0.764,P均<0.001)。与预后良好组比较,预后不良组年龄更大、体质指数更低、糖尿病的比例、NIHSS评分、Survivin,Hepc25水平更高、发病至入院时间更长(P<0.05)。多因素Logistic回归分析显示,年龄、NIHSS评分、Survivin,Hepc25为AIS患者预后不良的独立危险因素(P<0.05)。受试者工作特征(Receiver operating characteristic,ROC)曲线显示,血清Survivin,Hepc25水平联合预测AIS患者预后不良的曲线下面积>Survivin,Hepc25水平单独预测(P<0.05)。结论 AIS患者血清Survivin,Hepc25水平升高,与神经缺损程度加重和预后不良相关,可作为AIS患者预后不良的预测指标。
Abstract:
ObjectiveTo investigate the changes of serum survivin and iron-regulating factor 25(Hepc25)levels and clinical significance in patients with acute ischemic stroke(AIS).Methods A total of 105 AIS patients admitted to Anyang People's Hospital from June 2019 to June 2021 were selected as the AIS group, and another 53 physically healthy people were selected as the control group during the same period. 31 patients in the AIS group were divided into a mild deficit group, 49 patients in the moderate deficit group and 25 patients in the severe deficit group according to the National Institutes of Health Stroke Scale(NIHSS)score at admission. After 6 months, the AIS group was divided into 42 cases in the poor prognosis group and 63 cases in the good prognosis group according to the modified Rankin Scale. Serum Survivin and Hepc25 levels were measured by ELISA. Spearman's correlation coefficient was used to analyze the correlation between serum Survivin and Hepc25 levels and NIHSS scores in AIS patients, multi-factor logistic regression was used to analyze the factors influencing poor prognosis in AIS patients, and receiver operating characteristic(ROC)curves were used to analyze the value of serum Survivin and Hepc25 levels in predicting poor prognosis in AIS patients.Results Serum Survivin and Hepc25 levels were higher in the AIS group than in the control group(P<0.05). Serum Survivin and Hepc25 levels were sequentially increased in the mild, moderate and severe defect groups(P<0.05). Spearman's correlation coefficient showed that serum Survivin and Hepc25 levels were positively correlated with NIHSS scores in patients with AIS(r=0.693, 0.764, all P<0.001). The poor prognosis group was older, had a lower body mass index, a higher proportion of diabetes, NIHSS score, Survivin, Hepc25 levels and longer time from onset to admission compared to the good prognosis group(P<0.05). Multi-factor logistic regression analysis showed that age, NIHSS score, Survivin, and Hepc25 were independent risk factors for poor prognosis in patients with AIS(P<0.05). The ROC curve showed that the area under the curve for the combination of serum Survivin and Hepc25 levels to predict poor prognosis in AIS patients was greater than that predicted by Survivin and Hepc25 alone(P<0.05).Conclusion Elevated serum Survivin and Hepc25 levels in AIS patients are associated with increased degree of neurological deficit and poor prognosis, and can be used as a predictor of poor prognosis in AIS patients.

参考文献/References:

[1] 国家卫生计生委脑卒中防治工程委员会.中国脑卒中防治指导规范(2021年版)[EB/OL].2022, www.nhc.gov.cn/yzygj/s3593/202108/50c4071a86df4bfd9666e9ac2aaac605.shtml.
[2] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志,2019,52(4):1006-7876.
[3] Wu SM, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405.
[4] Feske SK. Ischemic stroke[J]. Am J Med, 2021, 134(12): 1457-1464.
[5] Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications[J]. Med Res Rev, 2022, 42(1): 259-305.
[6] 吴典.生存素在新生儿缺氧性肺动脉高压肺血管重塑中的作用机制研究进展[J].国际儿科学杂志,2020,47(6):407-410.
[7] 朱晓梦,安光祖,李铭明,等.过表达生存素对颅脑外伤大鼠神经细胞凋亡和神经功能的影响[J].中华实验外科杂志,2021,38(7):1287-1290.
[8] Azemin WA, Alias N, Ali AM, et al. Structural and functional characterisation of HepTH1-5 peptide as a potential hepcidin replacement[J]. J Biomol Struct Dyn, 2021, 6(2021): 1-24.
[9] Zhang X, Gou YJ, Zhang Y, et al. Hepcidin overexpression in astrocytes alters brain Iron metabolism and protects against amyloid-β induced brain damage in mice[J]. Cell Death Discov, 2020, 6(1): 113.
[10] Adams HJ, Bendixen BH, Kappelle LJ, et al. Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41.
[11] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):1006-7876.
[12] 张磊,刘建民.改良Rankin量表[J].中华神经外科杂志,2012,28(5):512.
[13] 国家神经系统疾病医疗质量控制中心.中国卒中学会.急性缺血性卒中再灌注治疗医疗质量评价与改进专家建议[J].中国卒中杂志,2021,16(7):1673-5765.
[14] Berge E, Whiteley W, Audebert H, et al. European stroke organisation(ESO)guidelines on intravenous thrombolysis for acute ischaemic stroke[J]. Eur Stroke J, 2021, 6(1): I-LXII.
[15] Mccullough LD, Roy-O'reilly M, Lai YJ, et al. Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice[J]. J Clin Invest, 2021, 131(17): e144898.
[16] Guzmán EA, Pitts TP, Tandberg KR, et al. Discovery of survivin inhibitors part 1: screening the harbor branch pure compound library[J]. Mar Drugs, 2021, 19(2): 73.
[17] Li Y, Lu W, Yang J, et al. Survivin as a biological biomarker for diagnosis and therapy[J]. Expert Opin Biol Ther, 2021, 21(11): 1429-1441.
[18] Sun JD, Li XM, Liu JL, et al. Effects of miR-150-5p on cerebral infarction rats by regulating the Wnt signaling pathway via p53[J]. Eur Rev Med Pharmacol Sci, 2020, 24(7): 3882-3891.
[19] Zhan L, Liu D, Wen H, et al. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation[J]. FASEB J, 2019, 33(8): 9291-9307.
[20] 王立一,王子豪,范照鑫,等.铁代谢在创伤性颅脑损伤中的研究进展[J].中国微侵袭神经外科杂志,2021,26(3):133-136.
[21] Yao MY, Liu T, Zhang L, et al. Role of ferroptosis in neurological diseases[J]. Neurosci Lett, 2021, 747(2021): 135614.
[22] Zhao Y, Xin Z, Li N, et al. Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating Iron metabolism[J]. Free Radic Biol Med, 2018, 124(2018): 1-11.
[23] Wang P, Cui Y, Ren Q, et al. Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosis[J]. Cell Death Dis, 2021, 12(5): 447.
[24] 朱蕊,曾庆,黄国志,等.铁死亡与脑卒中[J].中国组织工程研究,2021,25(23):3734-3739.
[25] Zhang Y, Lu X, Tai B, et al. Ferroptosis and its multifaceted roles in cerebral stroke[J]. Front Cell Neurosci, 2021, 15(2021): 615372.

相似文献/References:

[1]白文婷,杨丽荣,吕利英,等.多个危险因素聚集与急性缺血性脑卒中患者出院结局不良的关系[J].卒中与神经疾病杂志,2015,22(02):71.
[2]陈翠荣,赵振国,周媛,等.轻中度急性脑梗死MRI指导下超时间窗静脉溶栓治疗的研究[J].卒中与神经疾病杂志,2014,21(06):330.
[3]但毕堂,彭小祥,陈小奇,等.急性缺血性脑卒中时间窗内的动静脉溶栓分层治疗的对比研究[J].卒中与神经疾病杂志,2014,21(06):334.
[4]宗彦武,蔡柳燕,张岩.神经介入联合阿加曲班对急性缺血性脑卒中患者血清FIB,D-D表达水平的影响[J].卒中与神经疾病杂志,2022,29(04):365.[doi:10.3969/j.issn.1007-0478.2022.04.012]
[5]秦雅鑫 任占云 李杰 许冬华 叶沈早 陈蒋楠.Willis环完整性和脑白质变化对急性缺血性脑卒中患者神经功能缺损及预后的影响[J].卒中与神经疾病杂志,2023,30(03):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
　Qin Yaxin,Ren Zhanyun,Li Jie,et al.Effects of Willis ring integrity and white matter changes on neurological deficit and prognosis in patients with acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(05):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
[6]顾亮亮 王建锋 乔鑫 张保朝 傅国惠.急性缺血性脑卒中患者静脉溶栓前后SCUBE1水平的变化及其与预后不良的相关性分析[J].卒中与神经疾病杂志,2023,30(03):265.[doi:10.3969/j.issn.1007-0478.2023.03.006]
　Gu Liangliang*,Wang Jianfeng,Qiao Xin*,et al.Changes of SCUBE1 levels after thrombolytic therapy in patients with acute ischemic stroke and its correlation with prognosis[J].Stroke and Nervous Diseases,2023,30(05):265.[doi:10.3969/j.issn.1007-0478.2023.03.006]
[7]孙光文 徐仕皓 王媛媛 毛瑞 杨文琼.PTX3联合LP-PLA2水平与急性缺血性脑卒中合并颈动脉狭窄的关系[J].卒中与神经疾病杂志,2023,30(03):273.[doi:10.3969/j.issn.1007-0478.2023.03.008]
　Sun Guangwen*,Xu Shihao,Wang Ruanruan,et al.Correlation analysis of PTX3 combined with LP-PLA2 in carotid stenosis in acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(05):273.[doi:10.3969/j.issn.1007-0478.2023.03.008]
[8]龚汉贤,庄泽微,李述桃,等.球囊导引导管在老年急性缺血性脑卒中患者取栓治疗中的作用[J].卒中与神经疾病杂志,2024,(01):73.[doi:10.3969/j.issn.1007-0478.2024.01.012]

备注/Memo

备注/Memo:
基金项目:河南省医学科技攻关计划联合共建项目(LHG20191270)
更新日期/Last Update: 2022-10-10